ImmuPharma PLC (UK) Price History
| IMM Stock | 2.94 0.12 3.92% |
Below is the normalized historical share price chart for ImmuPharma PLC extending back to October 28, 2003. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ImmuPharma PLC stands at 2.94, as last reported on the 29th of March, with the highest price reaching 3.18 and the lowest price hitting 2.92 during the day.
If you're considering investing in ImmuPharma Stock, it is important to understand the factors that can impact its price. ImmuPharma PLC is out of control given 3 months investment horizon. ImmuPharma PLC holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12 % return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 3.13% are justified by taking the suggested risk. Use ImmuPharma PLC Market Risk Adjusted Performance of 2.43, downside deviation of 6.99, and Risk Adjusted Performance of 0.1109 to evaluate company specific risk that cannot be diversified away.
At present, ImmuPharma PLC's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 35.4 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 2.3 M. . ImmuPharma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 2.2698 | 50 Day MA 3.9336 | Beta 2.585 |
ImmuPharma |
Sharpe Ratio = 0.1213
| Best Portfolio | Best Equity | |||
| Good Returns | IMM | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 25.77 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.13 actual daily | 63 63% of assets have lower returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average ImmuPharma PLC is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ImmuPharma PLC by adding it to a well-diversified portfolio.
Price Book 4.7273 | Book Value 0.006 | Enterprise Value 12.5 M | Enterprise Value Ebitda (0.94) | Price Sales 60.7506 |
ImmuPharma PLC Stock Price History Chart
There are several ways to analyze ImmuPharma Stock price data. The simplest method is using a basic ImmuPharma candlestick price chart, which shows ImmuPharma PLC price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 28, 2025 | 5.9 |
| Lowest Price | January 3, 2025 | 1.1 |
ImmuPharma PLC March 29, 2025 Stock Price Synopsis
Various analyses of ImmuPharma PLC's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ImmuPharma Stock. It can be used to describe the percentage change in the price of ImmuPharma PLC from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ImmuPharma Stock.| ImmuPharma PLC Price Daily Balance Of Power | (0.46) | |
| ImmuPharma PLC Price Action Indicator | (0.17) | |
| ImmuPharma PLC Accumulation Distribution | 160,077 | |
| ImmuPharma PLC Price Rate Of Daily Change | 0.96 |
ImmuPharma PLC March 29, 2025 Stock Price Analysis
ImmuPharma Stock Price History Data
The price series of ImmuPharma PLC for the period between Sun, Dec 29, 2024 and Sat, Mar 29, 2025 has a statistical range of 4.8 with a coefficient of variation of 32.84. Under current investment horizon, the daily prices are spread out with arithmetic mean of 3.48. The median price for the last 90 days is 3.5. The company completed 1:1 stock split on 17th of August 2022. ImmuPharma PLC completed dividends distribution on 2021-12-14.| Open | High | Low | Close | Volume | ||
| 03/28/2025 | 3.00 | 3.18 | 2.92 | 2.94 | 1,957,859 | |
| 03/27/2025 | 3.20 | 3.24 | 2.76 | 3.06 | 6,093,293 | |
| 03/26/2025 | 3.30 | 3.39 | 3.13 | 3.19 | 3,768,190 | |
| 03/25/2025 | 3.27 | 3.65 | 3.23 | 3.30 | 2,171,642 | |
| 03/24/2025 | 3.34 | 3.64 | 3.21 | 3.44 | 1,421,733 | |
| 03/21/2025 | 3.40 | 3.72 | 3.26 | 3.50 | 3,057,544 | |
| 03/20/2025 | 3.33 | 3.37 | 3.11 | 3.34 | 1,346,185 | |
| 03/19/2025 | 3.40 | 3.57 | 3.11 | 3.40 | 1,671,358 | |
| 03/18/2025 | 3.48 | 3.81 | 3.23 | 3.40 | 1,121,111 | |
| 03/17/2025 | 3.32 | 3.90 | 3.32 | 3.56 | 6,018,235 | |
| 03/14/2025 | 3.30 | 3.46 | 3.07 | 3.29 | 4,432,991 | |
| 03/13/2025 | 3.90 | 4.50 | 3.32 | 3.40 | 13,797,243 | |
| 03/12/2025 | 3.15 | 3.50 | 3.05 | 3.36 | 1,728,253 | |
| 03/11/2025 | 3.20 | 3.37 | 3.01 | 3.25 | 2,649,199 | |
| 03/10/2025 | 3.45 | 3.68 | 3.22 | 3.50 | 1,744,098 | |
| 03/07/2025 | 3.20 | 3.60 | 3.10 | 3.47 | 3,361,529 | |
| 03/06/2025 | 3.40 | 3.56 | 3.11 | 3.18 | 1,996,678 | |
| 03/05/2025 | 3.40 | 3.60 | 3.21 | 3.30 | 1,978,342 | |
| 03/04/2025 | 3.50 | 3.65 | 3.40 | 3.55 | 2,668,008 | |
| 03/03/2025 | 3.65 | 3.78 | 3.50 | 3.53 | 1,866,101 | |
| 02/28/2025 | 3.80 | 3.88 | 3.41 | 3.55 | 5,527,958 | |
| 02/27/2025 | 3.92 | 4.19 | 3.83 | 3.83 | 1,292,204 | |
| 02/26/2025 | 3.90 | 4.11 | 3.83 | 4.00 | 2,913,738 | |
| 02/25/2025 | 4.16 | 4.18 | 3.82 | 3.90 | 4,445,167 | |
| 02/24/2025 | 4.33 | 4.44 | 4.02 | 4.02 | 2,821,394 | |
| 02/21/2025 | 4.55 | 4.67 | 4.13 | 4.20 | 2,591,531 | |
| 02/20/2025 | 4.60 | 4.68 | 4.30 | 4.60 | 1,587,541 | |
| 02/19/2025 | 4.48 | 5.15 | 4.38 | 4.68 | 10,188,077 | |
| 02/18/2025 | 4.03 | 4.38 | 3.85 | 4.31 | 4,675,491 | |
| 02/17/2025 | 4.04 | 4.22 | 3.90 | 3.92 | 3,848,846 | |
| 02/14/2025 | 3.80 | 4.09 | 3.74 | 4.01 | 5,711,090 | |
| 02/13/2025 | 4.01 | 4.25 | 3.75 | 3.80 | 14,259,671 | |
| 02/12/2025 | 4.50 | 4.88 | 4.20 | 4.31 | 3,020,362 | |
| 02/11/2025 | 4.81 | 5.15 | 4.50 | 4.70 | 3,413,263 | |
| 02/10/2025 | 4.50 | 5.50 | 4.50 | 4.82 | 5,376,993 | |
| 02/07/2025 | 3.91 | 5.30 | 3.60 | 4.58 | 14,026,283 | |
| 02/06/2025 | 4.20 | 4.90 | 3.50 | 3.90 | 11,373,456 | |
| 02/05/2025 | 5.02 | 5.30 | 4.00 | 4.51 | 7,630,794 | |
| 02/04/2025 | 5.02 | 5.60 | 5.00 | 5.00 | 4,588,885 | |
| 02/03/2025 | 5.02 | 5.54 | 4.70 | 5.10 | 4,054,294 | |
| 01/31/2025 | 5.60 | 6.50 | 5.02 | 5.20 | 13,751,765 | |
| 01/30/2025 | 4.52 | 5.80 | 4.00 | 5.40 | 11,400,560 | |
| 01/29/2025 | 6.00 | 6.40 | 4.60 | 4.89 | 23,878,735 | |
| 01/28/2025 | 5.90 | 7.40 | 5.10 | 5.90 | 64,061,820 | |
| 01/27/2025 | 4.50 | 7.14 | 3.70 | 5.50 | 49,527,031 | |
| 01/24/2025 | 3.60 | 4.50 | 3.00 | 4.05 | 34,232,853 | |
| 01/23/2025 | 2.74 | 3.60 | 2.63 | 3.60 | 5,919,621 | |
| 01/22/2025 | 2.84 | 3.50 | 2.68 | 2.84 | 6,027,129 | |
| 01/21/2025 | 3.00 | 3.40 | 2.60 | 3.08 | 3,058,403 | |
| 01/20/2025 | 3.55 | 3.94 | 3.00 | 3.15 | 7,811,130 | |
| 01/17/2025 | 2.41 | 3.60 | 2.41 | 3.35 | 9,729,339 | |
| 01/16/2025 | 3.09 | 3.09 | 2.30 | 2.63 | 4,926,496 | |
| 01/15/2025 | 3.21 | 3.49 | 2.76 | 2.90 | 10,956,385 | |
| 01/14/2025 | 4.00 | 4.00 | 3.20 | 3.20 | 13,200,710 | |
| 01/13/2025 | 3.80 | 4.40 | 3.00 | 3.75 | 19,975,590 | |
| 01/10/2025 | 3.41 | 4.90 | 2.59 | 3.55 | 86,083,213 | |
| 01/09/2025 | 1.40 | 4.00 | 1.40 | 3.50 | 113,741,123 | |
| 01/08/2025 | 1.21 | 1.35 | 1.20 | 1.20 | 1,505,232 | |
| 01/07/2025 | 1.16 | 1.35 | 1.13 | 1.25 | 1,245,164 | |
| 01/06/2025 | 1.20 | 1.29 | 1.07 | 1.15 | 518,778 | |
| 01/03/2025 | 1.14 | 1.29 | 1.03 | 1.10 | 975,120 |
About ImmuPharma PLC Stock history
ImmuPharma PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ImmuPharma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ImmuPharma PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ImmuPharma PLC stock prices may prove useful in developing a viable investing in ImmuPharma PLC
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 416.3 M | 437.1 M | |
| Net Loss | -7.4 M | -7 M |
ImmuPharma PLC Stock Technical Analysis
ImmuPharma PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
ImmuPharma PLC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ImmuPharma PLC's price direction in advance. Along with the technical and fundamental analysis of ImmuPharma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ImmuPharma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1109 | |||
| Jensen Alpha | 3.05 | |||
| Total Risk Alpha | 4.58 | |||
| Sortino Ratio | 0.4346 | |||
| Treynor Ratio | 2.42 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for ImmuPharma Stock analysis
When running ImmuPharma PLC's price analysis, check to measure ImmuPharma PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuPharma PLC is operating at the current time. Most of ImmuPharma PLC's value examination focuses on studying past and present price action to predict the probability of ImmuPharma PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuPharma PLC's price. Additionally, you may evaluate how the addition of ImmuPharma PLC to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |